Cadrenal Therapeutics News

Cadrenal Therapeutics | 8-K: Current report

Apr 9 21:30

Cadrenal Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

Apr 3 00:58

Cadrenal Therapeutics | 8-K: Current report

Mar 13 00:54

Cadrenal Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 12 20:42

Cadrenal Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Mar 12 20:07

Cadrenal Therapeutics | 8-K: Current report

Mar 11 21:16

Cadrenal Therapeutics | 8-K: Current report

Mar 6 06:31

Cadrenal Therapeutics | 8-K/A: Current report (Amendment)

Feb 15 21:07

Cadrenal Therapeutics | 8-K: Current report

Feb 13 05:53

Cadrenal Therapeutics | 8-K: Current report

Nov 9, 2023 22:15

Cadrenal Therapeutics | 8-K: Current report

Oct 24, 2023 05:04

Cadrenal Therapeutics | 8-K: Current report

Sep 9, 2023 04:10

Cadrenal Therapeutics | DEFA14A: Others

Sep 1, 2023 04:05

Cadrenal Therapeutics | DEFA14A: Others

Sep 1, 2023 04:05

Cadrenal Therapeutics | DEF 14A: Definitive information statements

Aug 29, 2023 04:55

Cadrenal Therapeutics | 8-K: Current report

Aug 18, 2023 18:06

Cadrenal Therapeutics | 8-K: Current report

Aug 17, 2023 04:10

Cadrenal Therapeutics | 8-K: Current report

Aug 10, 2023 21:16

Cadrenal Therapeutics | 8-K: Current report

Jul 24, 2023 21:20

Cadrenal Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933

Jul 24, 2023 21:15